Alexey Danilov
City of Hope Comprehensive Cancer Center

Dr. Danilov earned his medical degree and PhD at Yaroslavl State Medical Academy in Russia and completed a fellowship in hematology/oncology at Tufts Medical Center, in Boston, Massachusetts. He is a physician-scientist with background in molecular biology and oncologic drug development and expertise in cancer cell signaling. He leads an independent research program in B-cell malignancies which bridges the understanding of B-cell biology with early clinical evaluation of novel therapeutics.
In his role of an Associate Director, Toni Stephenson Lymphoma Center at City of Hope National Medical Center, Dr. Danilov directs an effort in experimental therapeutics in B-cell malignancies. In addition to pre-clinical focus on evaluation of novel targets in the ubiquitin-proteasome system (1) and oncogenic role of cyclin-dependent kinase-9 (2), his group performs correlative science on multiple clinical trials. He received peer-reviewed funding from the National Cancer Institute, Leukemia and Lymphoma Society, American Society of Hematology, Lymphoma Research Foundation and SWOG, and serves as Translational Medicine Chair at SWOG Lymphoma Committee.
Clinically, Dr. Danilov is a practicing medical oncologist specializing in the care of patients with lymphoma and CLL.


General Session

Debate- CLL: Debating Therapeutic Strategies

Saturday, October 19, 2024
2:40 PM - 2:50 PM
General Session

Q&A Session

Saturday, October 19, 2024
3:00 PM - 3:15 PM